Loading...
XJPX
6069
Market cap30mUSD
Jul 10, Last price  
684.00JPY
1D
0.29%
1Q
-2.98%
Jan 2017
102.97%
IPO
-65.71%
Name

Trenders Inc

Chart & Performance

D1W1MN
XJPX:6069 chart
P/E
22.70
P/S
0.59
EPS
30.13
Div Yield, %
3.96%
Shrs. gr., 5y
1.03%
Rev. gr., 5y
19.95%
Revenues
8.28b
+33.70%
461,064,000728,483,0001,195,976,0001,616,490,0001,839,236,0002,020,214,0001,494,931,0001,860,373,0002,165,784,0002,878,038,0003,079,986,0003,333,434,0006,557,825,0009,088,552,0005,673,575,0006,191,610,0008,278,331,000
Net income
217m
-63.91%
45,911,000109,525,000155,183,000248,948,00085,529,00060,835,00048,654,000141,446,000281,867,000317,195,000331,121,000311,636,000399,768,000708,820,000479,688,000600,742,000216,811,000
CFO
438m
-48.42%
146,197,000179,080,000155,047,00017,155,000237,829,000-61,894,000229,249,000192,507,000323,614,000227,699,000479,877,000589,709,000410,378,000259,329,999848,440,000437,618,000
Dividend
Mar 30, 202635 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 2000 and headquartered in Tokyo, Japan, Trenders, Inc. primarily operates within the marketing and investment sectors in the country. The firm delivers comprehensive promotional and public relations support services. Furthermore, Trenders oversees e-commerce platforms specifically for clinical products. Its broad range of activities also includes media oversight, acting as an agent for imported brand sales, developing and distributing digital books and web-based comics, and managing the entire lifecycle—from development to retail—of specialized cosmetic and health food items intended for clinical use.
IPO date
Oct 19, 2012
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT